antidiabetics

The following table of FDA approved doses has been created to assist in converting nonformulary medications to equivalent regimens of formulary sulfonylureas at the University of Kentucky Hospital. Second Generation Sulfonylureas
 * **Sulfonylurea Dosage Conversion Table** ||
 * **Drug** || **Equivalent Daily Dose** || **/Frequency** || **/Usual Dosage Range** ||
 * First Generation Sulfonylureas ||
 * //Acetohexamide// //(Dymelor//**®**//)// || 500 mg || QD-BID || 0.25-1.5 g ||
 * //Chlorpropamide// //(Diabinese//**®**//)// || 100-250 mg || QD || 0.1-0.5 g ||
 * **Tolazamide** (Tolinase**®**) || 250 mg || QD-BID || 0.2-1 g ||
 * //Tolbutamide// //(Orinase//**®**//)// || 1000 mg || BID-TID || 0.5-3 g ||
 * **Glimepiride** (Amaryl**®**) || 2 mg || QD || 1-8 mg ||
 * **Glipizide** (Glucotrol**®**) || 5-10 mg || QD-BID || 2.5-40 mg ||
 * **Glipizide extended release** (Glucotrol XL**®**) || 5 mg || QD || 5-20 mg ||
 * **Glyburide** (Diabeta**®**, Micronase**®**) || 2.5-5 mg || QD-BID || 1.25-20 mg ||
 * //**Micronized glyburide** (Glynase PresTab//**®**//)// || 3 mg || QD || 1.0-12 mg ||
 * Italicized agents are non-formulary
 * Italicized agents are non-formulary